Phase I
Showing 1 - 25 of >10,000
NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Phase I - Mirdametinib - Level 1
- +4 more
- (no location specified)
Jul 7, 2023
Mucopolysaccharidosis III-A Trial in Hamburg (JR-441)
Recruiting
- Mucopolysaccharidosis III-A
-
Hamburg, GermanyUniversitätsklinikum Hamburg-Eppendorf
Oct 18, 2023
Pneumococcal Disease Trial (XJ103 Injection, Placebo)
Not yet recruiting
- Pneumococcal Disease
- XJ103 Injection
- Placebo
- (no location specified)
Sep 6, 2023
Staphylococcus Aureus Bloodstream Infection Trial (XJ101 for Injection, Placebo)
Not yet recruiting
- Staphylococcus Aureus Bloodstream Infection
- XJ101 for Injection
- Placebo
- (no location specified)
Aug 25, 2023
Hematologic Malignancy Trial in Tianjin (BR108 injection)
Recruiting
- Hematologic Malignancy
- BR108 injection
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Aug 25, 2023
Advanced Malignant Tumor Trial (SHR-5495 for injection)
Not yet recruiting
- Advanced Malignant Tumor
- SHR-5495 for injection
- (no location specified)
Sep 26, 2023
Prostate Cancer Trial in Beijing, Shanghai (Phase I:[177Lu]Lu-XT033 Injection, Phase II:[177Lu]Lu-XT033 Injection)
Not yet recruiting
- Prostate Cancer
- Phase I:[177Lu]Lu-XT033 Injection
- Phase II:[177Lu]Lu-XT033 Injection
-
Beijing, Beijing, China
- +1 more
Oct 7, 2023
Advanced Solid Tumor Trial in Guangzhou (QLS1103)
Not yet recruiting
- Advanced Solid Tumor
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
May 23, 2023
Healthy Volunteers Trial in Beijing (RC1416(SAD), Placebo(SAD))
Recruiting
- Healthy Volunteers
- RC1416(SAD)
- Placebo(SAD)
-
Beijing, Beijing, ChinaChina-japan Friendship Hospital
Sep 27, 2023
Advanced Malignant Cancer Trial (HRS-7053 Injection)
Not yet recruiting
- Advanced Malignant Cancer
- HRS-7053 Injection
- (no location specified)
Aug 7, 2023
High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)
Not yet recruiting
- High-risk Non-muscle Invasive Bladder Cancer
- (no location specified)
Oct 25, 2023
Prostate Cancer Trial (HRS-9815 injection)
Not yet recruiting
- Prostate Cancer
- HRS-9815 injection
- (no location specified)
Sep 25, 2023
Non-muscular Invasive Bladder Cancer Trial in Changsha (BCG for therapeutic use)
Not yet recruiting
- Non-muscular Invasive Bladder Cancer
- BCG for therapeutic use
-
Changsha, ChinaHunan Cancer Hospital
Oct 20, 2023
Advanced Sarcoma Trial (NKG2D-CAR memory T cell)
Not yet recruiting
- Advanced Sarcoma
- NKG2D-CAR memory T cell
- (no location specified)
Oct 17, 2023
Advanced Malignancies Trial in Guangzhou (BRY812 for injection)
Not yet recruiting
- Advanced Malignancies
- BRY812 for injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital,Sun Yat-sen University
Sep 7, 2023
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)
Recruiting
- Metastatic Breast Cancer
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 26, 2023
Advanced Malignant Cancer Trial (SHR-2022 Injection)
Not yet recruiting
- Advanced Malignant Cancer
- SHR-2022 Injection
- (no location specified)
Nov 8, 2023
Solid Tumor, Positron-Emission Tomography(PET) Trial in Shanghai (68Ga-NOTA-SNA002)
Not yet recruiting
- Solid Tumor
- Positron-Emission Tomography(PET)
-
Shanghai, ChinaZhongshan Hospital Affiliated to Fudan University
Aug 4, 2023